<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="urn:hl7-org:v3" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="c3649858-77b7-2295-e053-2995a90a048f"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use GOLYTELY safely and effectively. See full prescribing information for GOLYTELY.
 <br/>
      <br/>
      <br/>
      <br/>
GOLYTELY (polyethylene glycol 3350 and electrolytes for oral solution)
 <br/>
      <br/>
Initial U.S. Approval: 1984
</title>
   <effectiveTime value="20210528"/>
   <setId root="57d22b0b-1ae0-4203-babc-f3bac17bd1c9"/>
   <versionNumber value="5"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id root="1.3.6.1.4.1.519.1" extension="107904591"/>
            <name>Braintree Laboratories, Inc.</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id root="1.3.6.1.4.1.519.1" extension="617357954"/>
                        <name>Braintree Laboratories, Inc.</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="52268-100" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="52268-101" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="52268-700" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="c3650190-2c4e-016b-e053-2995a90a0da2"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20210528"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="52268-100" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GoLYTELY</name>
                        <formCode code="C42973" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POWDER, FOR SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="236"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="G2M7P15E5P" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYETHYLENE GLYCOL 3350</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="G2M7P15E5P" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>POLYETHYLENE GLYCOL 3350</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="22.74"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="36KCS0R750" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM SULFATE ANHYDROUS</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="7IS9N8KPMG" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SULFATE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="6.74"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="8MDF5V39QO" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM BICARBONATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="HN1ZRA3Q20" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>BICARBONATE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="5.86"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="Q32ZN48698" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CHLORIDE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="2.97"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POTASSIUM CHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="295O53K152" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>POTASSIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="Q32ZN48698" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CHLORIDE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="4" unit="L"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="52268-100-01" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43173" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PLASTIC"/>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="active"/>
                                 <effectiveTime>
                                    <low value="19840713"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA019011" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19840713"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="52268-101" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GoLYTELY</name>
                        <formCode code="C42973" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POWDER, FOR SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="236"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="G2M7P15E5P" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYETHYLENE GLYCOL 3350</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="G2M7P15E5P" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>POLYETHYLENE GLYCOL 3350</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="22.74"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="36KCS0R750" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM SULFATE ANHYDROUS</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="7IS9N8KPMG" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SULFATE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="6.74"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="8MDF5V39QO" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM BICARBONATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="HN1ZRA3Q20" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>BICARBONATE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="5.86"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="Q32ZN48698" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CHLORIDE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="2.97"/>
                              <denominator unit="L" value="4"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POTASSIUM CHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="295O53K152" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>POTASSIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="Q32ZN48698" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CHLORIDE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="4" unit="L"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="52268-101-01" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43173" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PLASTIC"/>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="completed"/>
                                 <effectiveTime>
                                    <low value="19840713"/>
                                    <high value="20221031"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA019011" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="completed"/>
                           <effectiveTime>
                              <low value="19840713"/>
                              <high value="20221031"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <characteristic classCode="OBS">
                           <code code="SPLFLAVOR" codeSystem="2.16.840.1.113883.1.11.19255"/>
                           <value code="C73409" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PINEAPPLE" xsi:type="CE">
                              <originalText>PINEAPPLE</originalText>
                           </value>
                        </characteristic>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="52268-700" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>GoLYTELY</name>
                        <formCode code="C42973" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POWDER, FOR SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="227.1"/>
                              <denominator unit="L" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="G2M7P15E5P" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYETHYLENE GLYCOL 3350</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="G2M7P15E5P" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>POLYETHYLENE GLYCOL 3350</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="21.5"/>
                              <denominator unit="L" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="36KCS0R750" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM SULFATE ANHYDROUS</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="7IS9N8KPMG" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SULFATE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="6.36"/>
                              <denominator unit="L" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="8MDF5V39QO" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM BICARBONATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="HN1ZRA3Q20" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>BICARBONATE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="5.53"/>
                              <denominator unit="L" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="LYR4M0NH37" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>SODIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="Q32ZN48698" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CHLORIDE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="g" value="0.754"/>
                              <denominator unit="L" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POTASSIUM CHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="295O53K152" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>POTASSIUM CATION</name>
                                 </activeMoiety>
                              </activeMoiety>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="Q32ZN48698" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>CHLORIDE ION</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="4" unit="L"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="52268-700-01" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43199" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PACKET"/>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                           <subjectOf>
                              <marketingAct>
                                 <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 <statusCode code="completed"/>
                                 <effectiveTime>
                                    <low value="19840713"/>
                                    <high value="20220531"/>
                                 </effectiveTime>
                              </marketingAct>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA019011" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="completed"/>
                           <effectiveTime>
                              <low value="19840713"/>
                              <high value="20220531"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="L6df0fff9-dd55-45af-b8be-d82a9208ae09">
               <id root="c36424f6-91d8-226f-e053-2a95a90a6e9d"/>
               <code code="43683-2" codeSystem="2.16.840.1.113883.6.1" displayName="RECENT MAJOR CHANGES SECTION"/>
               <text>
                  <paragraph/>
               </text>
               <effectiveTime value="20210527"/>
               <excerpt>
                  <highlight>
                     <text>
                        <table border="0" width="100%">
                           <tbody>
                              <tr styleCode="First Last">
                                 <td>Warnings and Precautions, Aspiration: ( 
       <linkHtml href="#Lff7fbb4a-de0c-48d2-841c-d46b677d640e">5.7</linkHtml>)
      </td>
                                 <td align="right">05/2021</td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph/>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s2">
               <id root="c3649858-77b8-2295-e053-2995a90a048f"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE
</title>
               <text>
                  <paragraph>GoLYTELY is indicated for bowel cleansing prior to colonoscopy and barium enema X-ray examination in adults.
</paragraph>
               </text>
               <effectiveTime value="20210527"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>GoLYTELY is a combination of PEG 3350, an osmotic laxative, and electrolytes indicated for cleansing of the colon in preparation for colonoscopy and barium enema X-ray examination in adults (
         
 
    <linkHtml href="#s2">1</linkHtml>)
        

   </paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s3">
               <id root="c3649858-77ba-2295-e053-2995a90a048f"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION
</title>
               <effectiveTime value="20210527"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Preparation and Administration (
          
  
     <linkHtml href="#s4">2.1</linkHtml>): 
         
 
    </content>
                        </paragraph>
                        <list listType="unordered">
                           <item>Correct fluid and electrolyte abnormalities before treatment with GoLYTELY.</item>
                           <item>Reconstitute GoLYTELY with water prior to ingestion.</item>
                           <item>Do not take oral medications within 1 hour before the start or during administration of GoLYTELY. (
          
  
     <linkHtml href="#s4">2.1</linkHtml>)
         
 
    </item>
                           <item>Do not take other laxatives while taking GoLYTELY.</item>
                           <item>Consume only clear liquids; avoid red and purple liquids.</item>
                           <item>Consume water or other clear liquids up until 2 hours before the time of the colonoscopy.</item>
                           <item>Do not consume solid food within 2 hours before starting GoLYTELY.</item>
                        </list>
                        <paragraph>
                           <content styleCode="underline">Adult Dosing Regimen (
          
  
     <linkHtml href="#s5">2.2</linkHtml>): 
         
 
    </content>
                        </paragraph>
                        <list listType="unordered">
                           <item>On day prior to colonoscopy, instruct patients to consume a light breakfast at least 2 hours before starting GoLYTELY.</item>
                           <item>Begin the recommended dosage regimen for GoLYTELY early in the evening on the day before colonoscopy</item>
                           <item>Drink reconstituted solution at a rate of 8 ounces every 10 minutes, until 4 liters are consumed, or rectal effluent is clear.</item>
                           <item>For complete information on dosing, preparation and administration, see the full prescribing information. (
          
  
     <linkHtml href="#s4">2.1</linkHtml>, 
          
  
     <linkHtml href="#s5">2.2</linkHtml>)
         
 
    </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="s4">
                     <id root="c3649858-77bb-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1 Important Preparation and Administration Instructions</title>
                     <text>
                        <list listType="unordered">
                           <item>Correct fluid and electrolyte abnormalities before treatment with GoLYTELY 
          
  
   <content styleCode="italics">[see Warnings and Precautions (
           
   
    <linkHtml href="#La5521f5d-751a-4374-8fe9-b4334a7ed618">5.1</linkHtml>)]
          
  
   </content>.
         
 
  </item>
                           <item>Reconstitute GoLYTELY with water prior to ingestion, do not take undissolved GoLYTELY 
          
  
   <content styleCode="italics">[see Dosage and Administration (
           
   
    <linkHtml href="#s5">2.2</linkHtml>)]
          
  
   </content>. Do not reconstitute with other liquids and/or add starch-based thickeners to the mixing container 
          
  
   <content styleCode="italics">[see Warnings and Precautions (
           
   
    <linkHtml href="#Lff7fbb4a-de0c-48d2-841c-d46b677d640e">5.7</linkHtml>)]
          
  
   </content>.
         
 
  </item>
                           <item>Do not take oral medications within 1 hour before the start of or during administration of GoLYTELY 
          
  
   <content styleCode="italics">[see Drug Interactions (
           
   
    <linkHtml href="#s21">7.2</linkHtml>)]
          
  
   </content>.
         
 
  </item>
                           <item>Do not take other laxatives while taking GoLYTELY 
          
  
   <content styleCode="italics">[see Drug Interactions (
           
   
    <linkHtml href="#Lce548c6e-6f0c-42fc-8b64-ba88bc725ccb">7.3</linkHtml>)]
          
  
   </content>.
         
 
  </item>
                           <item>Consume only clear liquids, avoid red and purple liquids.</item>
                           <item>Patients may consume water or other clear liquids during the bowel preparation and after completion of the bowel preparation up until 2 hours before the time of the colonoscopy.</item>
                           <item>The solution is more palatable if chilled prior to administration.</item>
                           <item>Do not consume solid food within 2 hours before starting GoLYTELY. For the best results, do not consume solid food for 3 to 4 hours before drinking the solution.</item>
                           <item>If severe bloating, distention or abdominal pain occurs, slow or temporarily discontinue GoLYTELY until the symptoms abate.</item>
                        </list>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
               <component>
                  <section ID="s5">
                     <id root="c3649858-77bc-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2 Dosage Regimen</title>
                     <text>
                        <paragraph>Instruct adult patients that on the day before the colonoscopy procedure, they may consume a light breakfast at least 2 hours before starting GoLYTELY. Begin the recommended dosage regiment for GoLYTELY early in the evening on the day before colonoscopy.</paragraph>
                        <paragraph>Instruct patients to take GoLYTELY in conjunction with clear liquids as follows:</paragraph>
                        <paragraph>
                           <content styleCode="underline">﻿4 Liter Jug</content>
                        </paragraph>
                        <list listType="unordered">
                           <item>Fill the supplied container containing the GoLYTELY powder with lukewarm drinking water to the 4-liter fill line</item>
                           <item>Do not add any other ingredients, flavors, etc.</item>
                           <item>After capping the container, shake vigorously several times to ensure that the ingredients are dissolved.</item>
                           <item>Drink at a rate of 8 ounces every 10 minutes until the entire contents are consumed or the rectal effluent is clear. A loose watery bowel movement should result in approximately one hour.</item>
                           <item>After reconstitution, keep solution refrigerated 2° to 8°C (36° to 46°F). Do not freeze. Use within 48 hours, discard unused portion.</item>
                        </list>
                        <paragraph>
                           <content styleCode="underline">﻿Administration via a Nasogastric Tube</content>
                        </paragraph>
                        <paragraph>For patients with a nasogastric tube, administer the reconstituted GoLYTELY solution at a rate of 20 to 30 mL per minute (1.2 to 1.8 liters per hour).</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s7">
               <id root="c3649858-77bd-2295-e053-2995a90a048f"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS
</title>
               <text>
                  <paragraph>For Oral Solution: 236 g polyethylene glycol 3350, 22.74 g sodium sulfate (anhydrous), 6.74 g sodium bicarbonate, 5.86 g sodium chloride and 2.97 g potassium chloride as a white powder. When reconstituted with water to a volume of 4 liters, the solution contains 59 g/L PEG-3350, 5.69 g/L sodium sulfate, 1.69 g/L sodium bicarbonate, 1.47 g/L sodium chloride and 0.743 g/L potassium chloride.</paragraph>
               </text>
               <effectiveTime value="20200618"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>For Oral Solution: 236 g polyethylene glycol 3350, 22.74 g sodium sulfate (anhydrous), 6.74 g sodium bicarbonate, 5.86 g sodium chloride and 2.97 g potassium chloride per 4 liters.</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s8">
               <id root="c3649858-77be-2295-e053-2995a90a048f"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS
</title>
               <text>
                  <paragraph>GoLYTELY is contraindicated in the following conditions:</paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Gastrointestinal (GI) obstruction 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#Lbca0631e-a181-4b34-a1b7-ed8970b7d17d">5.6</linkHtml>)] 
        
  
   </content>
                     </item>
                     <item>Bowel perforation 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#Lbca0631e-a181-4b34-a1b7-ed8970b7d17d">5.6</linkHtml>)] 
        
  
   </content>
                     </item>
                     <item>Toxic colitis or toxic megacolon</item>
                     <item>Gastric retention</item>
                     <item>Ileus</item>
                     <item>Hypersensitivity to any component of GoLYTELY 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#L22f6fd59-0165-4479-9e2a-7cadc0f19a8d">5.8</linkHtml>)] 
        
  
   </content>
                     </item>
                  </list>
               </text>
               <effectiveTime value="20210527"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>Gastrointestinal (GI) obstruction (
          
  
     <linkHtml href="#s8">4</linkHtml>, 
          
  
     <linkHtml href="#Lbca0631e-a181-4b34-a1b7-ed8970b7d17d">5.6</linkHtml>)
         
 
    </item>
                           <item>Bowel perforation (
          
  
     <linkHtml href="#s8">4</linkHtml>, 
          
  
     <linkHtml href="#Lbca0631e-a181-4b34-a1b7-ed8970b7d17d">5.6</linkHtml>)
         
 
    </item>
                           <item>Toxic colitis or toxic megacolon (
          
  
     <linkHtml href="#s8">4</linkHtml>)
         
 
    </item>
                           <item>Gastric retention (
          
  
     <linkHtml href="#s8">4</linkHtml>)
         
 
    </item>
                           <item>Ileus (
          
  
     <linkHtml href="#s8">4</linkHtml>)
         
 
    </item>
                           <item>Hypersensitivity to components of GoLYTELY (
          
  
     <linkHtml href="#s8">4</linkHtml>, 
          
  
     <linkHtml href="#L22f6fd59-0165-4479-9e2a-7cadc0f19a8d">5.8</linkHtml>)
         
 
    </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s9">
               <id root="c3649858-77bf-2295-e053-2995a90a048f"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS
</title>
               <effectiveTime value="20210527"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>
                              <content styleCode="underline">Risk of fluid and electrolyte abnormalities</content>: Encourage adequate hydration, assess concurrent medications, and consider laboratory assessments prior to and after use. (
          
  
     <linkHtml href="#La5521f5d-751a-4374-8fe9-b4334a7ed618">5.1</linkHtml>, 
          
  
     <linkHtml href="#L7329172e-739e-446c-b2e7-d6e018c42cbd">5.2</linkHtml>, 
          
  
     <linkHtml href="#s20">7.1</linkHtml>)
         
 
    </item>
                           <item>
                              <content styleCode="underline">Cardiac arrhythmias</content>: Consider pre-dose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias. (
          
  
     <linkHtml href="#L7329172e-739e-446c-b2e7-d6e018c42cbd">5.2</linkHtml>)
         
 
    </item>
                           <item>
                              <content styleCode="underline">Seizures</content>: Use caution in patients with a history of seizures and patients at increased risk of seizure, including medications that lower the seizure threshold. (
          
  
     <linkHtml href="#L6028df95-9a44-45f1-aee5-07ad8073675a">5.3</linkHtml>, 
          
  
     <linkHtml href="#s20">7.1</linkHtml>)
         
 
    </item>
                           <item>
                              <content styleCode="underline">Patients with renal impairment or taking concomitant medications that affect renal function</content>: Use caution, ensure adequate hydration and consider testing. (
          
  
     <linkHtml href="#Lda9b1984-278c-4ff1-8937-b85b2d9df631">5.4</linkHtml>, 
          
  
     <linkHtml href="#s20">7.1</linkHtml>, 
          
  
     <linkHtml href="#L083e038f-9f82-4056-bfc3-f15cc76d167d">8.6</linkHtml>)
         
 
    </item>
                           <item>
                              <content styleCode="underline">Mucosal ulcerations</content>: Consider potential for mucosal ulcerations when interpreting colonoscopy findings in patients with known or suspected 
          
  
     <br/>inflammatory bowel disease. (
          
  
     <linkHtml href="#Ldc94455f-4359-419f-8ce0-d6719ed992fb">5.5</linkHtml>, 
          
  
     <linkHtml href="#Lce548c6e-6f0c-42fc-8b64-ba88bc725ccb">7.3</linkHtml>)
         
 
    </item>
                           <item>
                              <content styleCode="underline">Patients at risk for aspiration</content>: Observe during administration. (
          
  
     <linkHtml href="#Lff7fbb4a-de0c-48d2-841c-d46b677d640e">5.7</linkHtml>)
         
 
    </item>
                           <item>
                              <content styleCode="underline">Hypersensitivity reactions including anaphylaxis</content>: Inform patients to seek immediate medical care if symptoms occur. (
          
  
     <linkHtml href="#L22f6fd59-0165-4479-9e2a-7cadc0f19a8d">5.8</linkHtml>)
         
 
    </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="La5521f5d-751a-4374-8fe9-b4334a7ed618">
                     <id root="c3649858-77c0-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1 Serious Fluid and Serum Chemistry Abnormalities</title>
                     <text>
                        <paragraph>Advise patients to hydrate adequately before, during, and after the use of GoLYTELY. Use caution in patients with congestive heart failure when replacing fluids. If a patient develops significant vomiting or signs of dehydration including signs of orthostatic hypotension after taking GoLYTELY, consider performing post-colonoscopy lab tests (electrolytes, creatinine, and BUN) and treat accordingly. Fluid and electrolyte disturbances can lead to serious adverse events including cardiac arrhythmias, seizures and renal impairment. Correct fluid and electrolyte abnormalities before treatment with GoLYTELY.</paragraph>
                        <paragraph>In addition, use caution when prescribing GoLYTELY for patients who have conditions, or who are using medications, that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and renal impairment [ 
         
 
  <content styleCode="italics">see Drug Interactions (
          
  
   <linkHtml href="#s20">7.1</linkHtml>)
         
 
  </content>].
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
               <component>
                  <section ID="L7329172e-739e-446c-b2e7-d6e018c42cbd">
                     <id root="c3649858-77c1-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2 Cardiac Arrythmias</title>
                     <text>
                        <paragraph>There have been rare reports of serious arrhythmias associated with the use of ionic osmotic laxative products for bowel preparation. Use caution when prescribing GoLYTELY for patients at increased risk of arrhythmias (e.g., patients with a history of prolonged QT, uncontrolled arrhythmias, recent myocardial infarction, unstable angina, congestive heart failure, or cardiomyopathy). Consider pre-dose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias.</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
               <component>
                  <section ID="L6028df95-9a44-45f1-aee5-07ad8073675a">
                     <id root="c3649858-77c2-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3 Seizures</title>
                     <text>
                        <paragraph>There have been reports of generalized tonic-clonic seizures and/or loss of consciousness associated with use of bowel preparation products in patients with no prior history of seizures. The seizure cases were associated with electrolyte abnormalities (e.g., hyponatremia, hypokalemia, hypocalcemia, and hypomagnesemia) and low serum osmolality. The neurologic abnormalities resolved with correction of fluid and electrolyte abnormalities.</paragraph>
                        <paragraph>Use caution when prescribing GoLYTELY for patients with a history of seizures and in patients at increased risk of seizure, such as patients taking medications that lower the seizure threshold (e.g., tricyclic antidepressants), patients withdrawing from alcohol or benzodiazepines, or patients with known or suspected hyponatremia 
         
 
  <content styleCode="italics">[see Drug Interactions (
          
  
   <linkHtml href="#s20">7.1</linkHtml>)]
         
 
  </content>.
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
               <component>
                  <section ID="Lda9b1984-278c-4ff1-8937-b85b2d9df631">
                     <id root="c3649858-77c3-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.4 Renal Impairment</title>
                     <text>
                        <paragraph>Use caution when prescribing GoLYTELY for patients with impaired renal function or patients taking concomitant medications that may affect renal function (such as diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or non-steroidal anti-inflammatory drugs) 
         
 
  <content styleCode="italics">[see Drug Interactions (
          
  
   <linkHtml href="#s20">7.1</linkHtml>)]
         
 
  </content>. Advise these patients of the importance of adequate hydration and consider performing baseline and post-colonoscopy laboratory tests (electrolytes, creatinine, and BUN) in these patients 
         
 
  <content styleCode="italics">[see Use is Specific Populations (
          
  
   <linkHtml href="#L083e038f-9f82-4056-bfc3-f15cc76d167d">8.6</linkHtml>)]
         
 
  </content>.
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
               <component>
                  <section ID="Ldc94455f-4359-419f-8ce0-d6719ed992fb">
                     <id root="c3649858-77c4-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.5 Colonic Mucosal Ulcerations and Ischemic Colitis</title>
                     <text>
                        <paragraph>Administration of osmotic laxative products may produce colonic mucosal aphthous ulcerations, and there have been reports of more serious cases of ischemic colitis requiring hospitalization. Concurrent use of stimulant laxatives and GoLYTELY may increase this risk 
         
 
  <content styleCode="italics">[see Drug Interactions (
          
  
   <linkHtml href="#Lce548c6e-6f0c-42fc-8b64-ba88bc725ccb">7.3</linkHtml>)]
         
 
  </content>. Consider the potential for mucosal ulcerations resulting from the bowel preparation when interpreting colonoscopy findings in patients with known or suspect inflammatory bowel disease (IBD).
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
               <component>
                  <section ID="Lbca0631e-a181-4b34-a1b7-ed8970b7d17d">
                     <id root="c3649858-77c5-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.6 Use in Patients with Significant Gastrointestinal Disease</title>
                     <text>
                        <paragraph>If gastrointestinal obstruction or perforation is suspected, perform appropriate diagnostic studies to rule out these conditions before administering GoLYTELY 
         
 
  <content styleCode="italics">[see Contraindications (
          
  
   <linkHtml href="#s8">4</linkHtml>)]
         
 
  </content>. Use with caution in patients with severe active ulcerative colitis.
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
               <component>
                  <section ID="Lff7fbb4a-de0c-48d2-841c-d46b677d640e">
                     <id root="c3649858-77c6-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.7 Aspiration</title>
                     <text>
                        <paragraph>
                           <content styleCode="xmChange">Use with caution in patients with impaired gag reflex, unconscious, or semiconscious patients, and patients prone to regurgitation or aspiration. Observe these patients during administration of GoLYTELY, especially if it is administered via nasogastric tube.Use with caution in patients with impaired gag reflex, unconscious, or semiconscious patients, and patients prone to regurgitation or aspiration. Observe these patients during administration of GoLYTELY, especially if it is administered via nasogastric tube.</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="xmChange">Do not combine GoLYTELY with starch-based thickeners 
          
 
   <content styleCode="italics">[see Dosage and Administration (
           
  
    <linkHtml href="#s4">2.1</linkHtml>)]
          
 
   </content>. Polyethylene glycol (PEG), a component of GoLYTELY, when mixed with starch- thickened liquids reduces the viscosity of the starch-thickened liquid. When a PEG-based product used for another indication was mixed in starch-based pre-thickened liquids used in patients with dysphagia, thinning of the liquid occurred and cases of choking and potential aspiration were reported.
         

  </content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
               <component>
                  <section ID="L22f6fd59-0165-4479-9e2a-7cadc0f19a8d">
                     <id root="c3649858-77c7-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.8 Hypersensitivity Reactions</title>
                     <text>
                        <paragraph>GoLYTELY contains PEG and may cause serious hypersensitivity reactions including anaphylaxis, angioedema, rash, urticaria, and pruritus 
         
 
  <content styleCode="italics">[see Adverse Reactions (
          
  
   <linkHtml href="#s18">6</linkHtml>)]
         
 
  </content>. Inform patients of the signs and symptoms of anaphylaxis and instruct them to seek immediate medical care should signs and symptoms occur.
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s18">
               <id root="c3649858-77c8-2295-e053-2995a90a048f"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS
</title>
               <text>
                  <paragraph>The following clinically significant adverse reactions are described elsewhere in the labeling:</paragraph>
                  <paragraph/>
                  <list listType="unordered">
                     <item>Renal impairment 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#Lda9b1984-278c-4ff1-8937-b85b2d9df631">5.4</linkHtml>)] 
        
  
   </content>
                     </item>
                     <item>Colonic mucosal ulcerations and ischemic colitis 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#Ldc94455f-4359-419f-8ce0-d6719ed992fb">5.5</linkHtml>)] 
        
  
   </content>
                     </item>
                     <item>Patients with significant gastrointestinal disease 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#Lbca0631e-a181-4b34-a1b7-ed8970b7d17d">5.6</linkHtml>)] 
        
  
   </content>
                     </item>
                     <item>Aspiration 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#Lff7fbb4a-de0c-48d2-841c-d46b677d640e">5.7</linkHtml>)] 
        
  
   </content>
                     </item>
                  </list>
                  <paragraph>The following adverse reactions associated with the use of GoLYTELY were identified in clinical trials or postmarketing reports. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency, reliably, or establish a causal relationship to drug exposure.</paragraph>
                  <paragraph/>
                  <list listType="unordered">
                     <item>Cardiovascular: arrhythmia, atrial fibrillation, peripheral edema, asystole, and acute pulmonary edema after aspiration 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#L7329172e-739e-446c-b2e7-d6e018c42cbd">5.2</linkHtml>)] 
        
  
   </content>.
       
 
  </item>
                  </list>
                  <paragraph/>
                  <list listType="unordered">
                     <item>Nervous system: tremor, seizure 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#L6028df95-9a44-45f1-aee5-07ad8073675a">5.3</linkHtml>)] 
        
  
   </content>
                     </item>
                  </list>
                  <paragraph/>
                  <list listType="unordered">
                     <item>Hypersensitivity: Urticaria/rash, pruritus, dermatitis, rhinorrhea, dyspnea, chest and throat tightness, fever, angioedema, anaphylaxis and anaphylactic shock 
        
  
   <content styleCode="italics">[see Contraindications (
         
   
    <linkHtml href="#s8">4</linkHtml>), Warnings and Precautions (
         
   
    <linkHtml href="#L22f6fd59-0165-4479-9e2a-7cadc0f19a8d">5.8</linkHtml>)] 
        
  
   </content>
                     </item>
                  </list>
                  <paragraph/>
                  <list listType="unordered">
                     <item>Gastrointestinal: Nausea, abdominal fullness and bloating are the most common adverse reactions (occurred in up to 50% of patients). Other less common adverse reactions include: abdominal cramps, vomiting, “butterfly-like” infiltrates on chest X-ray after vomiting and aspirating PEG, anal irritation, and upper GI bleeding from Mallory-Weiss Tear, esophageal perforation [usually with gastroesophageal reflux disease (GERD)].</item>
                  </list>
               </text>
               <effectiveTime value="20210527"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Most common adverse reactions are: nausea, abdominal fullness, bloating, abdominal cramps, vomiting and anal irritation. (
         
 
    <linkHtml href="#s18">6</linkHtml>)
        

   </paragraph>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Braintree Laboratories, Inc. at 1-800-874-6756 or FDA at 1-800-FDA-1088 or </content>
                           <content styleCode="bold">
                              <content styleCode="italics">www.fda.gov/medwatch.</content>
                           </content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s19">
               <id root="c3649858-77c9-2295-e053-2995a90a048f"/>
               <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
               <title>7 DRUG INTERACTIONS
</title>
               <effectiveTime value="20210527"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Some drugs increase risks due to fluid and electrolyte changes (
         
 
    <linkHtml href="#s20">7.1</linkHtml>)
        

   </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="s20">
                     <id root="c3649858-77ca-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.1 Drugs that May Increase Risks Due to Fluid and Electrolyte Abnormalities</title>
                     <text>
                        <paragraph>Use caution when prescribing GoLYTELY for patients with conditions and/or who are using medications that increase the risk for fluid and electrolyte disturbances or may increase the risk of renal impairment, seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities [ 
         
 
  <content styleCode="italics">see Warnings and Precautions (
          
  
   <linkHtml href="#La5521f5d-751a-4374-8fe9-b4334a7ed618">5.1</linkHtml>, 
          
  
   <linkHtml href="#L7329172e-739e-446c-b2e7-d6e018c42cbd">5.2</linkHtml>, 
          
  
   <linkHtml href="#L6028df95-9a44-45f1-aee5-07ad8073675a">5.3</linkHtml>, 
          
  
   <linkHtml href="#Lda9b1984-278c-4ff1-8937-b85b2d9df631">5.4</linkHtml>)
         
 
  </content>]. Consider additional patient evaluations as appropriate.
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
               <component>
                  <section ID="s21">
                     <id root="c3649858-77cb-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.2 Potential for Reduced Drug Absorption</title>
                     <text>
                        <paragraph>GoLYTELY can reduce the absorption of other administered drugs. Administer oral medications within one hour before the start of administration of GoLYTELY 
         
 
  <content styleCode="italics">[see Dosage and Administration (
          
  
   <linkHtml href="#s4">2.1</linkHtml>)]
         
 
  </content>.
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
               <component>
                  <section ID="Lce548c6e-6f0c-42fc-8b64-ba88bc725ccb">
                     <id root="c3649858-77cc-2295-e053-2995a90a048f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>7.3 Stimulant Laxatives</title>
                     <text>
                        <paragraph>Concurrent use of stimulant laxatives and GoLYTELY may increase the risk of mucosal ulceration or ischemic colitis. Avoid use of stimulant laxatives (e.g., bisacodyl, sodium picosulfate) while taking GoLYTELY 
         
 
  <content styleCode="italics">[see Warnings and Precautions (
          
  
   <linkHtml href="#Ldc94455f-4359-419f-8ce0-d6719ed992fb">5.5</linkHtml>)]
         
 
  </content>.
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s23">
               <id root="c3649858-77cd-2295-e053-2995a90a048f"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS
</title>
               <effectiveTime value="20210527"/>
               <component>
                  <section ID="s24">
                     <id root="c3649858-77ce-2295-e053-2995a90a048f"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy
</title>
                     <text>
                        <paragraph>Animal reproduction studies have not been conducted with GoLYTELY. It is also not known whether GoLYTELY can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. GoLYTELY should be given to a pregnant woman only if clearly needed.</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
               <component>
                  <section ID="s25">
                     <id root="c3649858-77cf-2295-e053-2995a90a048f"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title>8.3 Nursing Mothers
</title>
                     <text>
                        <paragraph>It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when GoLYTELY is administered to a nursing woman.
</paragraph>
                     </text>
                     <effectiveTime value="20130930"/>
                  </section>
               </component>
               <component>
                  <section ID="s26">
                     <id root="c3649858-77d0-2295-e053-2995a90a048f"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use
</title>
                     <text>
                        <paragraph>Safety and effectiveness of GoLYTELY in pediatric patients have not been established.
</paragraph>
                     </text>
                     <effectiveTime value="20130930"/>
                  </section>
               </component>
               <component>
                  <section ID="s27">
                     <id root="c3649858-77d1-2295-e053-2995a90a048f"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use
</title>
                     <text>
                        <paragraph>Clinical studies of GoLYTELY did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.
</paragraph>
                     </text>
                     <effectiveTime value="20130930"/>
                  </section>
               </component>
               <component>
                  <section ID="L083e038f-9f82-4056-bfc3-f15cc76d167d">
                     <id root="c3649858-77d2-2295-e053-2995a90a048f"/>
                     <code code="88828-9" codeSystem="2.16.840.1.113883.6.1" displayName="RENAL IMPAIRMENT SUBSECTION"/>
                     <title>8.6 Renal Impairment</title>
                     <text>
                        <paragraph>Use GoLYTELY with caution in patients with renal impairment or patients taking concomitant medications that may affect renal function 
         
 
  <content styleCode="italics">[see Drug Interactions (
          
  
   <linkHtml href="#s20">7.1</linkHtml>)]
         
 
  </content>. These patients may be at risk for renal injury. Advise these patients of the importance of adequate hydration before, during and after use of GoLYTELY and consider performing baseline and post-colonoscopy laboratory tests (electrolytes, creatinine, and BUN) in these patients 
         
 
  <content styleCode="italics">[see Warnings and Precautions (
          
  
   <linkHtml href="#Lda9b1984-278c-4ff1-8937-b85b2d9df631">5.4</linkHtml>)]
         
 
  </content>.
        

 </paragraph>
                     </text>
                     <effectiveTime value="20210527"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s28">
               <id root="c3649858-77d3-2295-e053-2995a90a048f"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION
</title>
               <text>
                  <paragraph>GoLYTELY is a combination of polyethylene glycol 3350, an osmotic laxative, and electrolytes (sodium sulfate, sodium chloride, sodium bicarbonate and potassium chloride) for oral solution supplied in a 4-liter disposable jug containing 236 g polyethylene glycol 3350, 22.74 g sodium sulfate (anhydrous), 6.74 g sodium bicarbonate, 5.86 g sodium chloride, and 2.97 g potassium chloride as a white powder.</paragraph>
                  <paragraph>Polyethylene Glycol 3350, USP</paragraph>
                  <renderMultiMedia referencedObject="mm01"/>
                  <paragraph>Sodium Sulfate, USP</paragraph>
                  <paragraph>The chemical name is Na 
       
 
  <sub>2</sub>SO 
       
 
  <sub>4</sub>. The average Molecular Weight is 142.04. The structural formula is:
      

 </paragraph>
                  <renderMultiMedia referencedObject="mm02"/>
                  <paragraph>Sodium Bicarbonate, USP</paragraph>
                  <paragraph>The chemical name is NaHCO 
       
 
  <sub>3</sub>. The average Molecular Weight is 84.01. The structural formula is:
      

 </paragraph>
                  <renderMultiMedia referencedObject="mm03"/>
                  <paragraph>Sodium Chloride, USP</paragraph>
                  <paragraph>The chemical name is NaCl. The average Molecular Weight: 58.44. The structural formula is:</paragraph>
                  <paragraph>Na 
       
 
  <sup>+</sup> Cl 
       
 
  <sup>-</sup>
                  </paragraph>
                  <paragraph>Potassium Chloride, USP</paragraph>
                  <paragraph>The chemical name is KCl. The average Molecular Weight: 74.55. The structural formula is:</paragraph>
                  <paragraph>K-Cl</paragraph>
               </text>
               <effectiveTime value="20210527"/>
               <component>
                  <observationMedia ID="mm01">
                     <text>Polyethylene Glycol 3350 Structural Formula
</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="gol00-0002-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm02">
                     <text>Sodium Sulfate Structural Formula
</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="gol00-0002-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="mm03">
                     <text>Sodium Bicarbonate Structural Formula
</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="gol00-0002-03.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s29">
               <id root="c3649858-77d4-2295-e053-2995a90a048f"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY
</title>
               <effectiveTime value="20130930"/>
               <component>
                  <section ID="s30">
                     <id root="c3649858-77d5-2295-e053-2995a90a048f"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action
</title>
                     <text>
                        <paragraph>The primary mode of action is thought to be through the osmotic effect of polyethylene glycol 3350 which causes water to be retained in the colon and produces a watery stool.
</paragraph>
                     </text>
                     <effectiveTime value="20130930"/>
                  </section>
               </component>
               <component>
                  <section ID="s31">
                     <id root="c3649858-77d6-2295-e053-2995a90a048f"/>
                     <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                     <title>12.2 Pharmacodynamics
</title>
                     <text>
                        <paragraph>GoLYTELY induces as diarrhea which rapidly cleanses the bowel, usually within four hours.
</paragraph>
                     </text>
                     <effectiveTime value="20130930"/>
                  </section>
               </component>
               <component>
                  <section ID="s32">
                     <id root="c3649858-77d7-2295-e053-2995a90a048f"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics
</title>
                     <text>
                        <paragraph>The pharmacokinetics of PEG3350 following administration of GoLYTELY were not assessed. Available pharmacokinetic information for oral PEG3350 suggests that it is poorly absorbed.
</paragraph>
                     </text>
                     <effectiveTime value="20130930"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s35">
               <id root="c3649858-77d8-2295-e053-2995a90a048f"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING
</title>
               <text>
                  <paragraph>GoLYTELY (polyethylene glycol 3350 and electrolytes for oral solution) is supplied in a 4-liter disposable jug containing 236 g polyethylene glycol 3350, 22.74 g sodium sulfate (anhydrous), 6.74 g sodium bicarbonate, 5.86 g sodium chloride and 2.97 g potassium chloride as a white powder.</paragraph>
                  <list listType="unordered">
                     <item>When reconstituted with water to a volume of 4 liters, the solution contains 59 g/L PEG-3350, 5.69 g/L sodium sulfate, 1.69 g/L sodium bicarbonate, 1.47 g/L sodium chloride and 0.743 g/L potassium chloride.</item>
                  </list>
                  <paragraph>GoLYTELY 4 Liter Disposable Jug          NDC 52268-100-01</paragraph>
               </text>
               <effectiveTime value="20200618"/>
               <component>
                  <section ID="s39">
                     <id root="c3649858-77d9-2295-e053-2995a90a048f"/>
                     <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Storage</content>
                        </paragraph>
                        <paragraph>Store in sealed container at 15° to 30°C (59° to 86°F).</paragraph>
                        <paragraph>Store reconstituted solution of GoLYTELY at 2° to 8°C (36° to 46°F). Do not freeze 
         
 
  
         
 
  <content styleCode="italics">[see Dosage and Administration (
          
  
   
          
  
   <linkHtml href="#s4">2.1</linkHtml>)]
         
 
  
         
 
  </content>.
        

 
        

 </paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s40">
               <id root="c3649858-77da-2295-e053-2995a90a048f"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION
</title>
               <text>
                  <paragraph>Advise the patient to read the FDA-Approved Patient Labeling (Medication Guide and Instructions for Use).</paragraph>
                  <paragraph>Instruct Patients:</paragraph>
                  <list listType="unordered">
                     <item>To reconstitute GoLYTELY with water prior to ingestion.</item>
                     <item>Not to take other laxatives while they are taking GoLYTELY.</item>
                     <item>Not to take oral medications within 1 hour before the start or during the administration of GoLYTELY.</item>
                     <item>To take only clear liquids but avoid red and purple liquids.</item>
                     <item>To consume water or other clear liquids during the bowel preparation and after completion of the bowel preparation up until 2 hours before the time of the colonoscopy.</item>
                     <item>To follow the directions in the 
        
  
   <content styleCode="italics">Instructions for Use</content> on how to prepare and administer the product.
       
 
  </item>
                     <item>If they experience severe bloating, distention or abdominal pain, to slow or temporarily discontinue drinking the solution and to contact their healthcare provider.</item>
                     <item>To contact their healthcare provider if they develop signs and symptoms of dehydration or if they experience altered consciousness or seizures. 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#La5521f5d-751a-4374-8fe9-b4334a7ed618">5.1</linkHtml>, 
         
   
    <linkHtml href="#L7329172e-739e-446c-b2e7-d6e018c42cbd">5.2</linkHtml>, 
         
   
    <linkHtml href="#L6028df95-9a44-45f1-aee5-07ad8073675a">5.3</linkHtml>, 
         
   
    <linkHtml href="#Lda9b1984-278c-4ff1-8937-b85b2d9df631">5.4</linkHtml>)] 
        
  
   </content>.
       
 
  </item>
                     <item>To discontinue administration of the solution and contact their healthcare provider if they develop symptoms of a hypersensitivity reaction 
        
  
   <content styleCode="italics">[see Warnings and Precautions (
         
   
    <linkHtml href="#L22f6fd59-0165-4479-9e2a-7cadc0f19a8d">5.8</linkHtml>)] 
        
  
   </content>.
       
 
  </item>
                  </list>
                  <paragraph>Manufactured by Braintree Laboratories, Inc. 270 Centre Street Holbrook, MA 02343</paragraph>
                  <paragraph>Marketed by Braintree, a Part of Sebela Pharmaceuticals®. 60 Columbian Street West Braintree, MA 02185</paragraph>
               </text>
               <effectiveTime value="20210527"/>
            </section>
         </component>
         <component>
            <section ID="s41">
               <id root="c364cbfe-a2ef-76ef-e053-2a95a90a83ad"/>
               <code code="42231-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL MEDGUIDE SECTION"/>
               <text>
                  <table border="1" width="100%">
                     <tbody>
                        <tr>
                           <td align="center">
                              <paragraph>
                                 <content styleCode="bold">﻿Medication Guide</content>
                              </paragraph>
                              <paragraph>﻿GoLYTELY® (Go-lite-ly)</paragraph>
                              <paragraph>(PEG-3350 and Electrolytes)</paragraph>
                              <paragraph>for oral solution</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td>Read this Medication Guide before you start taking GoLYTELY. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.</td>
                        </tr>
                        <tr>
                           <td>
                              <paragraph>
                                 <content styleCode="bold">What is the most important information I should know about GoLYTELY?</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">GoLYTELY and other osmotic bowel preparations can cause serious side effects, including:</content>
                              </paragraph>
                              <paragraph>
                                 <content styleCode="bold">Serious loss of body fluid (dehydration) and changes in blood salts (electrolytes) in your blood.</content>
                                 <br/>
                                 <br/>
                                 <content styleCode="bold">These changes can cause:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>
                                    <content styleCode="bold">abnormal heartbeats (arrhythmias) that can cause death.</content>
                                 </item>
                                 <item>
                                    <content styleCode="bold">seizures. </content>This can happen even if you have never had a seizure.
      </item>
                                 <item>
                                    <content styleCode="bold">kidney problems.</content>
                                 </item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Your chance of having fluid loss and changes in body salts with GoLYTELY is higher if you:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>have heart problems.</item>
                                 <item>have kidney problems.</item>
                                 <item>take water pills or non-steroidal anti-inflammatory drugs (NSAIDS).</item>
                              </list>
                              <content styleCode="bold">Tell your healthcare provider right away if you have any of these symptoms of a loss of too much body fluid</content>
                              <br/>
                              <br/>
                              <content styleCode="bold">(dehydration) while taking GoLYTELY:</content>
                              <list listType="unordered">
                                 <item>vomiting that prevents you from keeping down the solution.</item>
                                 <item>dizziness.</item>
                                 <item>urinating less often than normal.</item>
                                 <item>headache.</item>
                              </list>
                              <content styleCode="bold">See Section “What are the possible side effects of GoLYTELY” for more information about side effects.</content>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <paragraph>
                                 <content styleCode="bold">What is GoLYTELY?</content>
                              </paragraph>
                              <paragraph>GoLYTELY is a prescription medicine used by adults to clean the colon before a colonoscopy or barium enema X-ray examination. GoLYTELY cleans your colon by causing you to have diarrhea (loose stools). Cleaning your colon helps your healthcare provider see the inside of your colon more clearly during your colonoscopy. It is not known if GoLYTELY is safe and effective in children.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <paragraph>
                                 <content styleCode="bold">﻿Who should not take GoLYTELY?</content>
                              </paragraph>
                              <paragraph>Do not take GoLYTELY if your healthcare provider has told you that you have:</paragraph>
                              <list listType="unordered">
                                 <item>a blockage in your bowel (obstruction).</item>
                                 <item>an opening in the wall of your stomach or intestine (bowel perforation).</item>
                                 <item>a very dilated intestine (toxic megacolon).</item>
                                 <item>problems with food and fluid emptying from your stomach (gastric retention).</item>
                                 <item>a problem with food moving too slowly through your intestines (ileus).</item>
                                 <item>an allergy to any of the ingredients in GoLYTELY. See the end of this Medication Guide for a complete list of ingredients in GoLYTELY.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <paragraph>
                                 <content styleCode="bold">What should I tell my healthcare provider before taking GoLYTELY?</content>
                                 <br/>
                                 <br/>
                                 <content styleCode="bold">Before you take GoLYTELY, tell your healthcare provider if you:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>have heart problems.</item>
                                 <item>have stomach or bowel problems.</item>
                                 <item>have ulcerative colitis.</item>
                                 <item>have problems with swallowing or gastric reflux.</item>
                                 <item>have a history of seizures.</item>
                                 <item>are withdrawing from drinking alcohol.</item>
                                 <item>have a low blood salt (sodium) level.</item>
                                 <item>have kidney problems.</item>
                                 <item>have any other medical conditions.</item>
                                 <item>are pregnant. It is not known if GoLYTELY will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant.</item>
                                 <item>are breastfeeding or plan to breastfeed. It is not known if GoLYTELY passes into your breast milk. You and your healthcare provider should decide if you will take GoLYTELY while breastfeeding.</item>
                              </list>
                              <paragraph>
                                 <content styleCode="bold">Tell your healthcare provider about all the medicines you take,</content> including prescription and over-the-counter medicines, vitamins, and herbal supplements.
     </paragraph>
                              <paragraph>GoLYTELY may affect how other medicines work. Do not take medicines by mouth within 1 hour of starting GoLYTELY or after you start taking GoLYTELY. 
      <content styleCode="bold">Especially tell your healthcare provider if you take:</content>
                              </paragraph>
                              <list listType="unordered">
                                 <item>medicines for blood pressure or heart problems.</item>
                                 <item>medicines for kidney problems.</item>
                                 <item>medicines for seizures.</item>
                                 <item>water pills (diuretics).</item>
                                 <item>non-steroidal anti-inflammatory medicines (NSAID) pain medicines.</item>
                                 <item>laxatives.</item>
                                 <item>starch-based thickeners. For patients who have trouble swallowing, do not mix GoLYTELY with starch-based thickeners.</item>
                              </list>
			Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure if you are taking any of the medicines listed above. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
    </td>
                        </tr>
                        <tr>
                           <td>
                              <paragraph>
                                 <content styleCode="bold">﻿How should I take GoLYTELY?</content>
                              </paragraph>
                              <paragraph/>
                              <paragraph>
                                 <content styleCode="bold">You must read, understand, and follow these instructions to take GoLYTELY the right way.</content>
                              </paragraph>
                              <paragraph/>
                              <list listType="unordered">
                                 <item>Take GoLYTELY exactly as your healthcare provider tells you to take it</item>
                                 <item>See the “Instructions for Use” on the bottle label for instructions on how to mix, take or give GoLYTELY.</item>
                                 <item>
                                    <content styleCode="bold">Do not take undissolved GoLYTELY powder that has not been mixed with water (diluted). It may increase your risk of nausea, vomiting and fluid loss (dehydration).</content>
                                 </item>
                                 <item>Do not take other laxatives while taking GoLYTELY.</item>
                                 <item>Drink reconstituted solution at a rate of 8 ounces (240 ml) every 10 minutes. Rapid drinking of each portion is better than drinking small amounts.</item>
                                 <item>
                                    <content styleCode="bold">Do not eat or drink anything colored red or purple.</content>
                                 </item>
                                 <item>
                                    <content styleCode="bold">Do not eat solid foods at least 2 hours before taking GoLYTELY.</content> You may eat a light breakfast 2 hours before taking GoLYTELY. For best results, do not consume solid food for 3 to 4 hours before drinking GoLYTELY.
      </item>
                                 <item>Drink only water and clear liquids:
       <br/>
                                    <br/>
				• the day before your colonoscopy
       <br/>
                                    <br/>
				• while taking GoLYTELY
       <br/>
                                    <br/>
				• after taking GoLYTELY until 2 hours before your colonoscopy.
      </item>
                                 <item>Drink clear liquids before, during, and after you take GoLYTELY to avoid fluid loss (dehydrated). Examples of clear liquids are:
       <br/>
                                    <br/>
				• water • clear broth
       <br/>
                                    <br/>
				• clear fruit juices without pulp including apple, white grape, • clear soda
       <br/>
                                    <br/>
				or white cranberry
       <br/>
                                    <br/>
				• strained limeade or lemonade • gelatin (without added fruit or topping)
       <br/>
                                    <br/>
				• coffee or tea (Do not use any dairy or non-dairy creamer) • popsicles without pieces of fruit or fruit pulp
      </item>
                                 <item>You may experience some abdominal bloating and distention before the bowels start to move. If severe discomfort or distention occur, slow or temporarily stop (discontinue) drinking the solution and contact your healthcare provider.</item>
                                 <item>The first bowel movement should occur approximately one hour after you start drinking the solution.</item>
                                 <item>Continue drinking until the watery stool is clear and free of solid matter.</item>
                              </list>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <paragraph>
                                 <content styleCode="bold">What are the possible side effects of GoLYTELY?</content>
                              </paragraph>
                              <paragraph>GoLYTELY can cause serious side effects, including:</paragraph>
                              <list listType="unordered">
                                 <item>
                                    <content styleCode="bold">See Section “What is the most important information I should know about GoLYTELY?”</content>
                                 </item>
                                 <item>
                                    <content styleCode="bold">changes in certain blood tests.</content> Your healthcare provider may do blood tests before and after you take GoLYTELY to check your blood for changes. Tell your healthcare provider if you have any symptoms of too much fluid loss, including:
       <br/>
                                    <br/>
				• vomiting • stomach (abdominal) cramping
       <br/>
                                    <br/>
				• nausea � • headache
       <br/>
                                    <br/>
				• bloating • urinate less than usual
       <br/>
                                    <br/>
				• dizziness • trouble drinking clear liquid
      </item>
                                 <item>
                                    <content styleCode="bold">ulcers of the bowel or bowel problems (ischemic colitis)</content>. Tell your healthcare provider right away if you have severe stomach-area (abdomen) pain or rectal bleeding.
      </item>
                              </list>
                              <paragraph>The most common side effects of GoLYTELY include:</paragraph>
                              <paragraph>• nausea • stomach (abdominal) cramps • anal irritation
      <br/>
                                 <br/>
			• stomach (abdominal) fullness • vomiting • esophageal bleeding
      <br/>
                                 <br/>
			• bloating • chest x-ray that shows water in
      <br/>
                                 <br/>
			the lungs (infiltrate) after
      <br/>
                                 <br/>
			vomiting or inhaling food or liquid
      <br/>
                                 <br/>
			(aspirate).
     </paragraph>
                              <paragraph>Tell your healthcare provider if you have any side effect that bothers you or that does not go away.</paragraph>
                              <paragraph>These are not all the possible side effects of GoLYTELY. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <paragraph>
                                 <content styleCode="bold">How should I store GoLYTELY?</content>
                                 <br/>
                                 <br/>
			• Store GoLYTELY in a sealed container at room temperature, between 59ºF to 86°F (15ºC to 30°C).
      <br/>
                                 <br/>
			• Store mixed (reconstituted) solution of GoLYTELY at 36° to 46°F (2°C to 8°C). Do not freeze.
      <br/>
                                 <br/>
			• Use mixed (reconstituted) solution of GoLYTELY within 48 hours.
      <br/>
                                 <br/>
			• After 48 hours, throw away (discard) any mixed (reconstituted) solution of GoLYTELY that is not used.
      <br/>
                                 <br/>
                                 <content styleCode="bold">Keep GoLYTELY and all medicines out of the reach of children.</content>
                              </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <paragraph>
                                 <content styleCode="bold">General information about the safe and effective use of GoLYTELY.</content>
                                 <br/>
                                 <br/>
			Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use GoLYTELY for a condition for which it was not prescribed. Do not give GoLYTELY to other people, even if they are going to have the same procedure you are. It may harm them.
      <br/>
                                 <br/>
			This Medication Guide summarizes important information about GoLYTELY. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information that is written for healthcare professionals.
     </paragraph>
                           </td>
                        </tr>
                        <tr>
                           <td>
                              <paragraph>
                                 <content styleCode="bold">What are the ingredients in GoLYTELY?</content>
                                 <br/>
                                 <br/>
			GoLYTELY comes in a 4-liter jug with GoLYTELY powder.
      <br/>
                                 <br/>
                                 <content styleCode="bold">Active ingredients:</content>
                                 <br/>
                                 <br/>
                                 <content styleCode="bold">Powder for solution:</content> polyethylene glycol 3350, sodium sulfate (anhydrous), sodium bicarbonate, sodium chloride, and potassium chloride.
     </paragraph>
                              <paragraph/>
                              <paragraph>Manufactured by Braintree Laboratories, Inc.
      <br/>
                                 <br/>
			270 Centre Street
      <br/>
                                 <br/>
			Holbrook, MA 02343
      <br/>
                                 <br/>
			Marketed by Braintree, a Part of Sebela Pharmaceuticals®
      <br/>
                                 <br/>
			60 Columbian Street West
      <br/>
                                 <br/>
			Braintree, MA 02185
      <br/>
                                 <br/>
			For more information go to www.braintreelabs.com or call 1-800-874-6756.
     </paragraph>
                           </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>This Medication Guide has been approved by the U.S. Food and Drug Administration.
  <br/>
Revised: 05/2021
 </paragraph>
               </text>
               <effectiveTime value="20210527"/>
            </section>
         </component>
         <component>
            <section ID="s42">
               <id root="c3649858-77dc-2295-e053-2995a90a048f"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>Principal Display Panel</paragraph>
                  <paragraph>
                     <content styleCode="bold">FILL TO THE TOP OF THE LINE ON BOTTLE</content>
                  </paragraph>
                  <paragraph>NDC 52268-100-01</paragraph>
                  <paragraph>
                     <content styleCode="bold">TO PHARMACIST AND PATIENT: </content>Mixing information is on base label.
      

 </paragraph>
                  <paragraph>Package insert may be removed before dispensing.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Dispense the enclosed Medication Guide to each patient.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">GoLYTELY
        
  
   <sup>®</sup>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">PEG-3350 and Electrolytes for Oral Solution</content>
                  </paragraph>
                  <paragraph>When reconstituted with water to a volume of 4 liters, this solution contains PEG-3350 59 g/L, sodium sulfate 5.69 g/L, sodium bicarbonate 1.69 g/L, sodium chloride 1.47 g/L, and potassium chloride 0.743 g/L.</paragraph>
                  <paragraph>Each disposable jug contains, in powdered form: polyethylene glycol 236 g, sodium sulfate (anhydrous) 22.74 g, sodium bicarbonate 6.74 g, sodium chloride 5.86 g, potassium chloride 2.97 g.</paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="italics">RX </content>
                     </content>
                     <content styleCode="bold">only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Manufactured by Braintree </content>
                     <content styleCode="bold">Laboratories, Inc., </content>
                     <content styleCode="bold">Braintree, MA 02185</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Marketed by Braintree, A part of Sebela Pharmaceuticals®</content>
                  </paragraph>
                  <paragraph/>
                  <paragraph>
                     <content styleCode="bold">
                        <renderMultiMedia referencedObject="L843ccb72-f380-4f45-92f1-05200aedc053"/>
                     </content>
                  </paragraph>
                  <paragraph/>
                  <paragraph>
                     <renderMultiMedia referencedObject="La1097b82-5364-4328-9b9d-ea08bc973b92"/>
                  </paragraph>
               </text>
               <effectiveTime value="20210527"/>
               <component>
                  <observationMedia ID="L843ccb72-f380-4f45-92f1-05200aedc053">
                     <text>GoLYTELY Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="GoLYTELY Label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="La1097b82-5364-4328-9b9d-ea08bc973b92">
                     <text>Base Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Base Label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="L6dc0ada7-de8b-41ce-8f31-ae6883660b08">
               <id root="c3649858-77dd-2295-e053-2995a90a048f"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">FILL TO THE TOP OF THE LINE ON BOTTLE</content>
                  </paragraph>
                  <paragraph>NDC 52268-101-01</paragraph>
                  <paragraph>
                     <content styleCode="bold">TO PHARMACIST AND PATIENT:</content>
                     <br/>Mixing information is on base
       
 
  <br/>label. Package insert may be
       
 
  <br/>removed before dispensing. Dispense the enclosed Medication Guide to each patient.
      

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">Pineapple Flavor</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">GoLYTELY®</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">PEG-3350 and Electrolytes for Oral Solution</content>
                  </paragraph>
                  <paragraph>When reconstituted with water to a volume of 4 liters, this solution contains 125 mmol/L sodium , 10 mmol/L potassium, 40 mmol/L sulfate, 20 mmol/L bicarbonate, 35 mmol/L chloride and 17.6 mmol/L polyethylene glycol 3350.</paragraph>
                  <paragraph>Each disposable jug contains, in powdered form: polyethylene glycol 3350 236 g, sodium sulfate (anhydrous) 22.74 g, sodium bicarbonate 6.74 g, sodium chloride 5.86 g, potassium chloride 2.97 g, flavor ingredients 3.0 g.</paragraph>
                  <paragraph>
                     <content styleCode="bold">RX only</content> M 9/13
      

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">Braintree</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Laboratories, Inc</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Braintree, MA 02185</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <renderMultiMedia referencedObject="Lda2b93c0-b5b4-4431-996b-ffbfd496b29a"/>
                     </content>
                  </paragraph>
               </text>
               <effectiveTime value="20210527"/>
               <component>
                  <observationMedia ID="Lda2b93c0-b5b4-4431-996b-ffbfd496b29a">
                     <text>Pineapple Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Pineapple Label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="L4ce0ac53-fea9-40b7-897a-c875436fa220">
               <id root="c3649858-77de-2295-e053-2995a90a048f"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>NDC 52268-700-01
       
 
  <br/>Rx only
      

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">GoLYTELY®</content>
                     <br/>
                     <content styleCode="bold">PEG-3350 AND ELECTROLYTES</content>
                     <br/>
                     <content styleCode="bold">FOR ORAL SOLUTION</content>
                     <br/>
                     <content styleCode="bold">1 Gallon (3.785 Liters)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Instructions</content>
                  </paragraph>
                  <paragraph>A GoLYTELY® solution is made up by dissolving the contents of this packet in one gallon of tap
       
 
  <br/>water according to the following procedure:
      

 </paragraph>
                  <paragraph>Obtain a food-grade clear container with a volume of at least one gallon.
       
 
  <br/>After cutting open the packet, pour the entire contents into the container.
       
 
  <br/>Add lukewarm drinking water to bring the volume of the solution to one gallon.
       
 
  <br/>Do not add any other ingredients, flavors, etc.
       
 
  <br/>Shake and/or mix thoroughly to ensure that the ingredients are dissolved.
       
 
  <br/>The solution is more palatable if chilled in the refrigerator before drinking. Keep reconstituted solution refrigerated. Use within 48 hours. Discard unused portion.
       
 
  <br/>For best results, no solid food should be consumed for the 3 to 4 hour period before drinking the solution; but in no case should solid food be eaten within two hours of taking GoLYTELY.
       
 
  <br/>Drink one 8 oz. glassful of the solution rapidly every 10 minutes. A loose watery bowel movement should result in approximately one hour. Continue drinking until the rectal effluent is clear or the entire contents (1 gallon) have been consumed or as directed by your physician.
       
 
  <br/>Usual dosage: 1 gallon (3.785 liters).
       
 
  <br/>This package contains:
       
 
  <br/>Polyethylene glycol 3350…..227.1 grams
       
 
  <br/>Sodium sulfate, anhydrous….21.5 grams
       
 
  <br/>Sodium bicarbonate………….6.36 grams
       
 
  <br/>Sodium chloride………………5.53 grams
       
 
  <br/>Potassium chloride…………..2.82 grams
      

 </paragraph>
                  <paragraph>APPROXIMATE NET WEIGHT: 263 grams
       
 
  <br/>Distributed by Braintree Laboratories, Inc., Braintree, MA 02185
      

 </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="Lc6d02b26-0868-4414-844d-3ad9a390ffc0"/>
                  </paragraph>
               </text>
               <effectiveTime value="20210527"/>
               <component>
                  <observationMedia ID="Lc6d02b26-0868-4414-844d-3ad9a390ffc0">
                     <text>Packets Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Packets Label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>